Klotho Market Cap from 2010 to 2026

KLTO Stock   0.34  0.01  3.03%   
Klotho Neurosciences Market Cap yearly trend continues to be very stable with very little volatility. Market Cap is likely to drop to about 10.2 M. During the period from 2010 to 2026, Klotho Neurosciences Market Cap quarterly data regression pattern had sample variance of 175505.5 T and median of  1,076,207,201. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
10.7 M
Current Value
10.2 M
Quarterly Volatility
418.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Klotho Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Klotho Neurosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 730.5 K, Selling General Administrative of 6.7 M or Selling And Marketing Expenses of 598, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 8.6. Klotho financial statements analysis is a perfect complement when working with Klotho Neurosciences Valuation or Volatility modules.
  
Build AI portfolio with Klotho Stock
Check out the analysis of Klotho Neurosciences Correlation against competitors.
To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.

Latest Klotho Neurosciences' Market Cap Growth Pattern

Below is the plot of the Market Cap of Klotho Neurosciences over the last few years. It is Klotho Neurosciences' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Klotho Neurosciences' overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Klotho Market Cap Regression Statistics

Arithmetic Mean888,068,787
Geometric Mean471,935,010
Coefficient Of Variation47.17
Mean Deviation309,875,035
Median1,076,207,201
Standard Deviation418,933,814
Sample Variance175505.5T
Range1.1B
R-Value(0.66)
Mean Square Error105309.7T
R-Squared0.44
Significance0
Slope(54,871,588)
Total Sum of Squares2808088.6T

Klotho Market Cap History

202610.2 M
202510.7 M
20249.3 M

About Klotho Neurosciences Financial Statements

Klotho Neurosciences investors utilize fundamental indicators, such as Market Cap, to predict how Klotho Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Market Cap10.7 M10.2 M

Pair Trading with Klotho Neurosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klotho Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klotho Neurosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Klotho Stock

  0.9LIPO Lipella PharmaceuticalsPairCorr

Moving against Klotho Stock

  0.93ATI Allegheny TechnologiesPairCorr
  0.88BAC Bank of America Earnings Call TomorrowPairCorr
  0.85DD Dupont De NemoursPairCorr
  0.84XOM Exxon Mobil CorpPairCorr
  0.82ACR-PC ACRES Commercial RealtyPairCorr
The ability to find closely correlated positions to Klotho Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klotho Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klotho Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klotho Neurosciences to buy it.
The correlation of Klotho Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klotho Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klotho Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klotho Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Klotho Neurosciences is a strong investment it is important to analyze Klotho Neurosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Klotho Neurosciences' future performance. For an informed investment choice regarding Klotho Stock, refer to the following important reports:
Check out the analysis of Klotho Neurosciences Correlation against competitors.
To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Klotho Neurosciences. If investors know Klotho will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Klotho Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.30)
Return On Assets
(0.72)
Return On Equity
(1.98)
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Klotho Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Klotho Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Klotho Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.